EUCRU
Closed
Eucrates Biomedical Acquisition Corp.
10.02
0.00 (0.00%)
Last Update: 05 May 2023 16:30:00
Yesterday: 10.02
Day's Range: 10.02 - 10.02
Send
sign up or login to leave a comment!
When Written:
10.37
Eucrates Biomedical Acquisition Corp. is a special purpose acquisition company (SPAC) that was formed in 2021. The company was created with the purpose of acquiring or merging with one or more businesses operating in the life sciences and healthcare industry. The company is listed on the NASDAQ stock exchange under the ticker symbol EBACU.
The management team of Eucrates Biomedical Acquisition Corp. includes experienced professionals from the healthcare and finance industries, including CEO Dr. Rajiv Shukla, who has over 20 years of experience in the pharmaceutical industry.
The company raised $150 million in its initial public offering (IPO) in March 2021, with the intention of using the funds to acquire a target company in the healthcare industry. As of September 2021, the company has not yet announced any specific acquisition targets.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The management team of Eucrates Biomedical Acquisition Corp. includes experienced professionals from the healthcare and finance industries, including CEO Dr. Rajiv Shukla, who has over 20 years of experience in the pharmaceutical industry.
The company raised $150 million in its initial public offering (IPO) in March 2021, with the intention of using the funds to acquire a target company in the healthcare industry. As of September 2021, the company has not yet announced any specific acquisition targets.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








